EG436003 Inhibitors
EG436003 inhibitors are a class of chemical compounds characterized by their ability to inhibit the biological activity of the EG436003 target protein. These inhibitors are typically small molecules designed to bind to specific regions of the EG436003 protein, thereby modulating its activity at the molecular level. The design of these inhibitors often relies on detailed structural and biochemical information about the EG436003 protein, including its binding pockets, conformation, and the key amino acids involved in its function. Structurally, EG436003 inhibitors may possess a variety of chemical scaffolds, often containing aromatic rings, heterocyclic moieties, and functional groups such as hydroxyls, amides, or sulfonamides that enhance their binding affinity and specificity to the target protein. The precise nature of these chemical modifications is tailored to improve the interaction between the inhibitor and EG436003, ensuring effective binding and inhibition. This specificity in structure-function relationships makes these inhibitors particularly potent in modulating the activity of the EG436003 protein.
In terms of their chemical behavior, EG436003 inhibitors typically exhibit favorable physicochemical properties that enable them to interact efficiently with the EG436003 target protein. These properties include suitable lipophilicity, which allows for membrane permeability, and appropriate molecular weight, which facilitates binding and cellular uptake. Additionally, their design often aims for a balance between stability and reactivity, ensuring that the inhibitor can maintain its active form under biological conditions while effectively binding to the target protein. The binding mechanisms of EG436003 inhibitors often involve non-covalent interactions such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, which contribute to their specificity and potency. The development of EG436003 inhibitors also considers their selectivity, aiming to minimize off-target interactions that could lead to undesired biological effects. As a result, these inhibitors play a crucial role in modulating the activity of the EG436003 protein through precise and targeted binding, providing a valuable tool for studying the function of this protein in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Deferoxamine | 70-51-9 | sc-507390 | 5 mg | $255.00 | ||
Deferoxamine is a direct inhibitor of Hbb-bh2 by chelating iron ions, disrupting heme binding activity and oxygen carrier activity. Its sequestration of iron impacts the oxygen transport function, inhibiting Hbb-bh2's predicted role in oxygen transport and heme-related activities. | ||||||
Phenylhydrazine | 100-63-0 | sc-250701 sc-250701A | 5 g 100 g | $45.00 $52.00 | ||
Phenylhydrazine directly inhibits Hbb-bh2 by inducing hemolysis, impacting hemoglobin binding and oxygen carrier activity. Its disruption of hemoglobin functions influences Hbb-bh2's predicted roles in oxygen transport and heme-related activities. | ||||||
Sodium nitrite | 7632-00-0 | sc-203393A sc-203393B sc-203393 | 25 g 100 g 500 g | $20.00 $22.00 $41.00 | 1 | |
Sodium Nitrite directly inhibits Hbb-bh2 by oxidizing heme, impacting oxygen carrier activity. Its influence on heme chemistry disrupts the gene's predicted role in oxygen transport and heme-related activities, inhibiting crucial functions associated with hemoglobin. | ||||||
L-Cysteine | 52-90-4 | sc-286072 sc-286072A sc-286072B sc-286072C sc-286072D | 25 g 100 g 500 g 5 kg 10 kg | $51.00 $112.00 $449.00 $1151.00 $2178.00 | 1 | |
L-Cysteine indirectly inhibits Hbb-bh2 by promoting glutathione synthesis, influencing glutathione metabolic processes. Its impact on glutathione directly influences Hbb-bh2's predicted role in the regulation of glutathione metabolism, suggesting an indirect regulatory mechanism. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Sodium Azide is a direct inhibitor of Hbb-bh2 by binding to heme, disrupting oxygen binding and transport. Its interaction with heme directly influences the gene's predicted role in oxygen carrier activity and oxygen transport, inhibiting these crucial functions. | ||||||
Acetaminophen | 103-90-2 | sc-203425 sc-203425A sc-203425B | 25 g 100 g 500 g | $41.00 $61.00 $194.00 | 11 | |
Acetaminophen is an indirect inhibitor of Hbb-bh2 by promoting glutathione depletion, impacting glutathione metabolic processes. Its influence on glutathione directly influences Hbb-bh2's predicted role in the regulation of glutathione metabolism, suggesting an indirect regulatory mechanism. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin indirectly inhibits Hbb-bh2 by modulating peroxidase activity. Its impact on peroxidase function indirectly influences Hbb-bh2's predicted role in the catabolism of hydrogen peroxide, highlighting a potential indirect regulatory mechanism for inhibiting this gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is an indirect inhibitor of Hbb-bh2 by influencing haptoglobin binding activity. Its interference with haptoglobin binding indirectly influences Hbb-bh2's predicted role in haptoglobin-hemoglobin complex formation, suggesting an indirect regulatory mechanism for inhibiting this gene. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium (meta)arsenite indirectly inhibits Hbb-bh2 by promoting oxidative stress, impacting peroxidase activity. Its influence on peroxidase function indirectly influences Hbb-bh2's predicted role in the catabolism of hydrogen peroxide, highlighting a potential indirect regulatory mechanism for inhibiting this gene. | ||||||